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interventional occlusion of the hypogastric artery in
patients undergoing endovascular aortic aneurysm
repair
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Nirvana Sadaghianloo, MD,a,b Jean Baqué, MD,a,d Pierre-Edouard Magnan, MD,c and
Réda Hassen-Khodja, MD,a,b Nice and Marseille, France
Objective: The aim of this study was to analyze the pelvic ischemic complications and their impact on quality of life
after interventional occlusion of the hypogastric artery (IOHA) in patients undergoing endovascular aortic aneurysm
repair (EVAR).
Methods: Between January 2004 and April 2012, 638 consecutive patients with aortoiliac aneurysm treated by EVAR were
prospectively registered in two teaching hospitals. We identiﬁed all EVAR patients who underwent IOHA. Demographic,
clinical, and radiologic data were extracted from electronic databases and patient records as requested. All patients who
survived the postoperative period took part in a quality of life survey, the Walking Impairment Questionnaire (WIQ),
which included four items: pain, distance, walking speed, and stair climbing. Outcome measures included the 30-day rate
of pelvic ischemic complications, the buttock claudication (BC) rate at 30 days and during follow-up, and the comparative
WIQ scores between patients with persistent BC, those with regressive BC, and those who never had BC after the IOHA
procedure.
Results: A total of 71 patients (97% men; mean age, 76 years 6 7.69) required 75 IOHA procedures. These were deemed
proximal in 44 cases and distal in 31, with use of coil embolization in 64%, Amplatzer plug in 24%, or a combination of
coils and plugs in 12%. The technical success rate was 100%. Two patients (2.8%) experienced fatal acute pelvic ischemic
complications in the postoperative period after EVAR. Another patient died of iliac rupture during EVAR, leading to an
operative mortality rate of 4.3%. Eighteen patients (25.3%) suffered BC, among whom 11 cases resolved at a median
follow-up of 42 months. Young age (odds ratio, 0.92; 95% conﬁdence interval, 0.85-0.99; P [ .03) and distal IOHA
(odds ratio, 3.5; 95% conﬁdence interval, 1.01-11.51; P [ .04) were independent predictors of BC occurrence. The
actuarial rate of persistent BC was 85% at 18 months. The WIQ scores were lower for patients with persistent BC (median
score, 35.04; interquartile range, 16.36; P [ .001) compared with patients with regressive BC (median score, 76.5;
interquartile range, 36.66; P[ .02) or those who never experienced BC after the IOHA procedure (median score, 65.34;
interquartile range, 10.94; P < .0003).
Conclusions: Pelvic ischemia associated with IOHA may be severe and lead to fatality after EVAR. Our data show that BC
may lead to severe quality of life impairment when it does not regress during follow-up. (J Vasc Surg 2014;60:40-9.)Interventional occlusion of the hypogastric artery
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://dx.doi.org/10.1016/j.jvs.2014.01.039the iliac artery bifurcations. Potential drawbacks include a
higher incidence of pelvic ischemia, with acute or chronic
clinical consequences such as sciatic nerve palsy, paraplegia,
gluteal necrosis, colonic ischemia, and buttock claudication
(BC).1-6 This last complication is particularly frequent but
often ignored or considered benign by clinicians. The full
effect of BC, as a marker of chronic pelvic ischemia, and
its impact on patients’ daily walking ability may be under-
estimated. Poor clinical assessment criteria, lack of prospec-
tively collected data in reported series, and possible
confusion with common mobility-limiting conditions in
the target population make the evaluation of BC even
more difﬁcult.
Assessment of functional capacity and walking ability is
important in determining disease severity, evaluating treat-
ment, and assessing quality of life in claudicants.7 Treadmill
testing is the standard measure to assess walking ability as
expressed in meters. However, there is often discrepancy
between subjectively experienced daily walking ability,
Fig 1. An example of distal hypogastric embolization for associated hypogastric artery (HA) aneurysm. Note the
selective placement of coils in all efferent branches from the hypogastric aneurysmal sac.
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measured on a treadmill in a vascular laboratory.7-10 A
more qualitative approach to document daily walking abil-
ity is the Walking Impairment Questionnaire (WIQ),
which has been used in several studies to evaluate the effect
of treatment in patients with peripheral arterial disease.11-15
Current literature contains few data regarding the
impact of chronic pelvic ischemia on a patient’s daily
walking ability, functional capacity, and quality of life after
IOHA. The aim of this study was to analyze the pelvic
ischemic complications and their impact on the patient’s
quality of life after IOHA in the setting of EVAR by use
of the WIQ.
METHODS
Consecutive patients with aortoiliac aneurysm treated
by EVAR between January 2004 and April 2012 were pro-
spectively registered in two teaching hospitals. We retro-
spectively identiﬁed all EVAR patients who underwent
unilateral or bilateral IOHA to obtain suitable distal land-
ing zones for the endografts. Sacriﬁce of any hypogastric
artery (HA) was performed in the setting of EVAR for pa-
tients deemed at high risk for open repair, when a bell-
bottom technique (early in our experience) or an iliac
side-branch (later in our experience) was anatomically un-
feasible. Our criteria to deﬁne high risk for open repair
were reported elsewhere.16 Depending on anatomy and
operator preference, patients who needed endograft exten-
sion to both external iliac arteries (EIAs) underwent staged
bilateral IOHA or unilateral IOHA with preservation of the
contralateral HA. This was achieved by contralateral iliac
side-branch endografting, contralateral bell-bottom tech-
nique, EIA-HA endobypass, or surgical reimplantation of
the HA into the EIA. Demographic, clinical, and radiologic
data were extracted from prospectively maintained elec-
tronic databases and patient records as requested. Age
of the patients, gender, comorbid conditions, anatomicindications for IOHA, status of the contralateral HA, and
outcomes and technical details of IOHA procedures and
any adjunctive procedures were recorded for analysis.
IOHA procedures were classiﬁed as proximal or distal
according to the placement of the embolization materials,
which were respectively placed before or beyond the HA
bifurcation. Typically, proximal IOHA was carried out
whenever it was anatomically possible by occluding the
HA before the bifurcation, except when the presence of
an HA aneurysm or ectasia precluded ﬂush occlusion. In
these circumstances, distal IOHA was performed by inter-
rupting the primary branches feeding the HA aneurysm sac
(Fig 1).
The procedure was performed with a C-arm or in the
angiography suite under local, locoregional, or general
anesthesia, as appropriate. The interval between IOHA
and EVAR procedures was decided by the surgeon and
recorded. Technical success for the IOHA was deﬁned as
the absence of any antegrade ﬂow distal to the emboliza-
tion material on the completion angiogram. All periopera-
tive complications were registered and investigated
clinically or paraclinically as appropriate, especially the ma-
jor acute pelvic ischemic complications. According to Chai-
kof et al,17 instances of sciatic nerve palsy or paraplegia
lasting for more than 24 hours, grade II or III colonic
ischemia, and fatal gluteal necrosis were considered major
acute pelvic ischemic complications.
During follow-up, both general and EVAR-speciﬁc
complications were recorded. All patients underwent
routine clinical examination, plain ﬁlm abdominal radio-
graphy, and duplex scan or computed tomography angio-
graphy at discharge and at 6-month intervals for the ﬁrst
postoperative year and annually thereafter. Special atten-
tion was paid to BC as a marker of chronic pelvic ischemia
during each of these postoperative clinic visits. BC was
deﬁned as walking-induced buttock pain that forces pa-
tients to stop after a speciﬁc distance or time. Treadmill
Table I. Clinical baseline characteristics
Baseline characteristics No. (%) (N ¼ 71)
Hypertension 49 (69)
Dyslipidemia 24 (34)
Diabetes mellitus 9 (13)
Lower extremity occlusive diseasea 19 (27)
Smoking 58 (82)
Ongoing 26
Pastb 32
Never 13
Previously symptomatic coronary artery disease 24 (34)
Cardiac insufﬁciencyc 9 (13)
Respiratory insufﬁciencyd 23 (32)
Renal failure 39 (55)
Mild (GFRe < 80 mL/min) 19
Moderate (GFR < 60 mL/min) 14
Severe (GFR < 30 mL/min) 3
Chronic hemodialysis 3
GFR, Glomerular ﬁltration rate.
aInfraclinical (six cases), intermittent limb claudication (four cases), previous
successful limb revascularization procedures (nine cases), instances of critical
limb ischemia (none).
bSmoking cessation for more than 1 year.
cOvert manifestations of heart failure or ejection fraction below 40%.
dEvidenced by forced expiratory volume in the ﬁrst second of expiration of
less than 1.2 L; vital capacity below 50% of the predicted value as a function
of age, sex, and weight; arterial PaCO2 > 45 mm Hg or PaO2 < 60 mm Hg;
or home oxygen therapy.
eGFR as estimated from Cockroft and Gault formula for patients younger
than 65 years or the Modiﬁcation of Diet in Renal Disease formula for
patients older than 65 years.
Fig 2. Kaplan-Meier curve for all-cause mortality. N at risk,
Number at risk; SE, standard error. The arrow indicates where SE
is >10%.
Table II. Causes of death during follow-up
No.a (%) (N ¼ 68) Timing, month
General causes 7 (10)
Cancer 3 (4) M27, M21, M8
Cardiovascular 3 (4) M72, M66, M47
Respiratory insufﬁciency 1 (1.5) M49
Aneurysm-related death 2 (3)
Certain 0 (0)
Probableb 1 (1.5) M38
Unknown 1 (1.5) M36
aExcluding the three patients who died during the 30-day postoperative
period.
bThis patient had declined a secondary procedure for contralateral type Ib
endoleak.
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performed, but BC was graded according to Fontaine clas-
siﬁcation as stage 2B or 2A for, respectively, maximum (re-
ported) walking distance superior or inferior to
200 meters.18 The time elapsed between the IOHA proce-
dure and the complete regression of the BC symptoms was
also recorded. Patients with ongoing BC at the end of
follow-up were deemed to have persistent BC.
For the impact of persistent BC on the patient’s daily
walking ability and functional capacity to be determined,
all surviving patients were invited between May 2012 and
November 2012 to participate in a quality of life survey
(the WIQ). This was completed at ﬁnal follow-up during
the last outpatient visit, with the exception of a limited
number of patients who requested mail or phone adminis-
tration. The WIQ (Appendix, online only) is a disease-
speciﬁc health-related quality of life survey that consists
of four subscales exploring four important factors of
walking impairment in patients with intermittent claudica-
tion: pain, distance, speed, and ability to climb stairs. For
each separate domain, subscores of the Likert items were
calculated with a Likert scale from 0 (extremely disabling)
to 5 (not at all disabling). The subscores were weighted
and expressed in percentages of the maximum possible
score. Regarding the pain subscale, there were two sets of
questions: set A targeted intermittent claudication from
vascular origin, and set B targeted walking limitations
from other conditions (eg, shortness of breath, joint pain,stiffness or aching, chest pain or discomfort). Walking
impairment was not deemed to be of vascular origin
when set B score was superior to set A score.15
The study protocol was approved by our local institu-
tional ethics committee, and all patients gave informed con-
sent to publish their data. Outcome measures included the
30-day rate of major acute pelvic ischemic complications,
the BC rate at 30 days after discharge from the hospital,
and the cumulative frequency of persistent BC as a measure
of chronic pelvic ischemia. Further analysis included the
comparative WIQ scores at ﬁnal follow-up between pa-
tients with persistent BC, those with regressive BC, and
those who never had BC after the IOHA procedure.
Statistical analysis. Statistical analysis was carried out
with SPSS v.20.0 (IBM Corp, Armonk, NY). Categorical
variables were compared by c2 test signiﬁcance analysis or
Fisher exact test and expressed as a proportion. Continuous
Table III. Endovascular aneurysm repair (EVAR)-speciﬁc complications
Occurrence Main cause Management Outcomes
Endoleaksa
Type Ia M36 Proximal neck aneurysmal evolution Palmaz stent Favorable at M69
Type Ib M13 Contralateral distal aneurysmal evolution Patient declined treatment Death at M38
Type III M5 Limb migration Stent graft limb addition Favorable at M36
Stent graft limb occlusion
Ipsilateral IOHA M3 ND Femoral-femoral bypass Favorable at M17
Ipsilateral IOHA M54 ND Conservativeb Favorable at M58
IOHA, Interventional occlusion of the hypogastric artery; ND, not determined.
aEleven patients were diagnosed with type II endoleaks and treated conservatively because of spontaneous regression (seven cases) or stable aneurysm sac
diameters (four cases).
bNondisabling intermittent thigh claudication treated conservatively.
Table IV. Univariate analysis (end point: buttock claudication [BC] at 30 days)
Variable BC, % (No.) P value
Age, years (mean 6 standard deviation) 72 6 7.9 vs 77 6 7.5 .02
Unilateral vs bilateral IOHA 24 (19/67) vs 25 (1/4) .74
Single- vs two-stage procedure 31 (5/16) vs 24 (13/55) .53
Proximal vs distala 18 (9/50) vs 43 (9/21) .03
Smokers vs nonsmokers 27 (15/55) vs 19 (3/16) .49
Coils vs plugs 28 (15/53) vs 17 (3/18) .32
Patent vs occluded contralateral HA 28 (16/58) vs 15 (2/13) .49
Aortouni-iliac vs aortobi-iliac conﬁguration 22 (4/18) vs 26 (14/53) >.99
Lower extremity occlusive disease (yes/no) 16 (3/19) vs 29 (15/52) .36
HA, Hypogastric artery; IOHA, interventional occlusion of the hypogastric artery.
aConcomitant ectatic hypogastric artery or aneurysm requiring ultradistal embolization.
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Whitney U test and expressed as mean 6 standard devia-
tion or as median with the range and the interquartile
range (IQR). For multiple comparisons, the Kruskal-Wallis
test was applied and followed by Bonferroni post hoc
correction. Linear regression was used to assess the cross-
sectional relationship between WIQ subscores and the
time elapsed between the IOHA procedure and the date of
survey completion. Cumulative frequencies of individual
clinical outcomes were generated by the Kaplan-Meier
method. The associations between potential predictors
and chronic pelvic ischemia were assessed by univariate
methods followed by stepwise multivariate logistic regres-
sion analysis. Statistical signiﬁcance was set at P # .05.
RESULTS
Population description. Among 638 patients who
underwent EVAR during the study period, we identiﬁed
71 patients (69 men, two women) who required IOHA.
The mean age of this cohort was 75.8 6 7.69 years. Clin-
ical baseline characteristics are listed in Table I. For suitable
distal landing zones to be obtained for 53 bifurcated and
18 aortouni-iliac endografts, a total of 75 HAs were
occluded intentionally in these 71 patients. The main
anatomic reasons for interrupting the HA were an insufﬁ-
cient distal neck (<10 mm) in the common iliac artery (51
cases), an associated HA aneurysm (23 cases), or a short
(<30 mm) common iliac artery in the last patient. The
IOHA procedure was unilateral in 67 patients (94%) andbilateral in 4 patients (6%); the latter group included three
cases of associated bilateral HA aneurysm and one case of
unsuitable distal landing zone in both common iliac ar-
teries. All four bilateral IOHA cases were performed as a
staged procedure. Five other patients of the unilateral
group had prior chronic contralateral HA occlusion from
atheromatous lesions. This resulted in a total of 13% of
patients (9 of 71) with bilateral HA interruption. In nine
other patients who would have otherwise required a
bilateral IOHA procedure, we performed some adjunctive
procedures to preserve antegrade perfusion to the contra-
lateral HA. These included two cases of contralateral iliac
side-branch endografting, two cases of endobypass be-
tween the HA and EIAs (banana technique), two cases of
surgical reimplantation of the HA into the EIA, and three
cases of the bell-bottom technique. Among the remaining
patients, the contralateral HA was patent and deemed
healthy in 40 (56%), ectatic in 8 (11%), or with signiﬁcant
($70%) stenoses in 5 (7%).
Procedural results. The IOHA procedure was carried
out by coil embolization in 48 HAs (64%), the Amplatzer
plug in 18 arteries (24%), or a combination of coils and
plugs in 9 arteries (12%). The IOHA was deemed proximal
in 59% of cases (44 arteries in 42 patients) and distal in 41%
(31 arteries in 29 patients). The latter group contained the
23 patients with associated HA aneurysms. All IOHA pro-
cedures were successfully completed, achieving an initial
100% technical success rate. This was performed in the
same operative setting as EVAR in 16 patients (18%) or
Fig 3. Kaplan-Meier curve for persistent buttock claudication
(BC). N at risk, Number at risk; SE, standard error. The arrow
indicates where SE is >10%.
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time elapsed between the two procedures was 11 days
(IQR, 2-20 days; range, 0-103 days). Unplanned adjunc-
tive procedures were required at the time of EVAR to
deal with three instances of intraprocedural adverse events.
An 83-year-old patient experienced acute stent graft
thrombosis treated by axillobifemoral bypass after failed
thrombectomy attempts. A second patient had acute stent
graft limb occlusion ipsilateral to the embolized HA. A
crossover femoral-femoral bypass was performed after
failed thrombectomy attempts. A third patient underwent
contralateral HA reimplantation into the EIA because of
inadvertent coverage of this artery during EVAR.
Thirty-day postoperative outcomes. Within the ﬁrst
30 days after the EVAR procedure, two patients (2.8%)
experienced fatal acute pelvic ischemic complications: one
case of colonic ischemia and one case of partially resolutive
paraplegia. The former was an 82-year-old patient who
underwent unilateral IOHA and EVAR in two sessions and
suffered stent graft thrombosis 48 hours after EVAR. The
latter was a 73-year-old patient who became paraplegic the
day after EVAR, with the occlusion of the contralateral
internal-external iliac endobypass diagnosed on computed
tomography angiography. Another patient died of iliac
rupture during EVAR before any salvage procedure could
be performed, leading to a 30-day mortality rate of 4.3%
(3 of 71). In addition, there were two cases of stent graft
limb occlusion ipsilateral to the IOHA, at days 14 and 28
after EVAR, which were successfully treated by a crossover
femoral-femoral bypass. No cases of gluteal necrosis were
observed, but the previously mentioned patient who
experienced paraplegia displayed a gluteal ischemic rash. In
addition, three systemic nonfatal complications were noted:
renal failure worsening in two patients and acute coronarysyndrome in another. For comparative purposes, in EVAR
patients who did not undergo an IOHA procedure, no
cases of acute pelvic ischemia were diagnosed, and the 30-
day death rate was 1.2% (7 of 563) during the same period
(P ¼ .06).
Medium-term outcomes. The median follow-up was
42 months (IQR, 21-72 months; range, 1-105 months).
During this period, there were 13 deaths (Fig 2), including
the three cases of in-hospital mortality mentioned before
and 10 later deaths. Five-year survival rate was 77%. The
death causes are summarized in Table II. No late
aneurysm-related deaths attributable to the IOHA proce-
dure were documented, but two patients died of unknown
causes, including one patient who declined a secondary
procedure for a type Ib contralateral endoleak. Sexual
dysfunction was not routinely sought with a dedicated
questionnaire, but a 61-year-old patient reported erectile
dysfunction 2 months after the IOHA procedure. Table III
details the principal EVAR-speciﬁc complications depicted
in this cohort during follow-up, with their time and cause
of occurrence, dedicated treatment, and outcomes. No
complication was directly attributable to the IOHA,
although two patients showed stent graft limb occlusion
ipsilateral to the sacriﬁced HA (Table III).
No further patients were diagnosed with acute pelvic
ischemia during follow-up. Concerning chronic pelvic
ischemic symptoms, 18 patients (25.3%) suffered BC at
30 days after discharge from the hospital. BC was catego-
rized as Fontaine stage 2B in 11 patients (61%) and 2A
in 7 (39%). Three BC cases were bilateral. In contrast,
inadvertent coverage of one HA occurred in three cases
of the 567 other EVAR patients during the same period
but had remained totally asymptomatic. In univariate anal-
ysis (Table IV), patients who experienced BC after IOHA
were signiﬁcantly younger than the nonclaudicants (72 6
7.9 years vs 77 6 7.5 years; P ¼ .02). The frequency of
BC was also higher (43% [9 of 21] vs 18% [9 of 50];
P ¼ .03) in patients who underwent distal IOHA for asso-
ciated HA aneurysm (Fig 1). All other factors (Table IV)
were nonsigniﬁcant. In multivariate analysis, young age
(odds ratio, 0.92; 95% conﬁdence interval, 0.85-0.99;
P ¼ .03) and distal IOHA for associated HA aneurysm
(odds ratio, 3.5; 95% conﬁdence interval, 1.01-11.51;
P ¼ .04) remained the only independent predictors of
BC occurrence after IOHA.
During the median follow-up of 42 months, 11 cases
of BC resolved spontaneously and none worsened with
time. Fig 3 shows the cumulative frequency of persistent
BC. In patients with persistent BC, the median time
elapsed between the IOHA procedure and the last
follow-up visit was 42 months (IQR, 32-75 months; range,
10-92 months). The actuarial rate of persistent BC (Fig 3)
was 85% at 18 months.
Chronic pelvic ischemia and quality of life scores.
A total of 58 patients, excluding the 13 previously
mentioned death cases, were invited to participate in the
quality of life survey. Eight patients could not complete
the WIQ because of their neurologic status (stroke, four
Fig 4. Walking Impairment Questionnaire (WIQ) subscores plotted as a function of follow-up month. Linear
regression of WIQ subscores and cross-sectional follow-up month are shown. A,WIQ pain (set A). B,WIQ pain (set B).
C, WIQ pain (total). D, WIQ distance. E, WIQ speed. F, WIQ stair climbing. P values are by Pearson correlation.
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response rate. Timing of survey completion from the
IOHA procedure varied from patient to patient (median,
45.5 months; IQR, 24-78 months). Linear regression of
each of the four WIQ subscale scores with cross-sectional
follow-up month is illustrated in Fig 4. There was no sta-
tistically signiﬁcant association between longer follow-up
and any of the four WIQ subscale linear regression co-
efﬁcients. Fig 5 shows a detailed comparison of WIQ
subscores between three groups of patients: those with
persistent BC, those with regressive BC, and those who
never had BC. Patients who experienced persistent BC
showed signiﬁcantly poorer subscores for walk pain (set A
subscore [P < .0003] and total [P ¼ .0003]), walk distance
(P < .0003), and stair climbing (P ¼ .0003) as opposed to
patients who never had BC. The subscores also differed
between patients with persistent BC and those with
regressive BC, although this did not reach statistical sig-
niﬁcance for distance (P ¼ .06) and stair climbing (P ¼
.18). There were no subscore differences in any of the four
WIQ subscales when patients with regressive BC were
compared with those who never had BC. Similarly, the
total WIQ score, indicating functional capacity and walking
ability as quality of life markers, did not differ between
patients with regressive BC and those who never experi-
enced BC (P > .999 [Bonferroni correction]). The totalWIQ score was, however, signiﬁcantly lower in patients with
persistent BC (median score, 35.04; IQR, 16.36; Kruskal-
Wallis test, P¼ .001) compared with patients with regressive
BC (median score, 76.5; IQR, 36.66; Bonferroni correction,
P¼ .02) or those who never experienced BC after the IOHA
procedure (median score, 65.34; IQR, 10.94; Bonferroni
correction, P< .0003). All three groups of patients displayed
comparable subscores for WIQ pain set B questions that
target nonvascular walking impairment from common
mobility-limiting conditions. Further analysis showed that
regardless of the time elapsed between survey completion and
the IOHAprocedure (Fig 6), patients with persistent BC had
signiﬁcantly poorer WIQ total scores and subscores (pain A,
distance, and stair climbing) than those of patients with
regressive BC or patients who never had claudication.
DISCUSSION
In this study, we focused on pelvic ischemia, patient
functional capacity, and walking ability as quality of life
markers after IOHA in the setting of EVAR. Our ﬁndings
conﬁrm that acute pelvic ischemia associated with IOHA
occurs rarely but can be severe and, in some cases, fatal.
In this study, chronic pelvic ischemic symptoms as under-
lined by BC were more common and likely to be relevant
in the youngest patients who underwent distal IOHA
for associated HA aneurysm. Our data also show that
Fig 5. Walking Impairment Questionnaire (WIQ) subscores in patients with ongoing or persistent buttock claudi-
cation (BC), those with regressive BC, and those who never had BC after hypogastric artery (HA) embolization
procedures. Signiﬁcant P values by Kruskal-Wallis test were followed by Bonferroni post hoc correction. A, WIQ pain
(set A questions): [persistent BC vs regressive BC; P ¼ .015]; [persistent BC vs no BC ever; P < .0003]; [regressive BC
vs no BC ever; P ¼ .11]. B, WIQ pain (set B questions): No statistically signiﬁcant differences between the three
groups. C, WIQ pain (total): [persistent BC vs regressive BC; P ¼ .015]; [persistent BC vs no BC ever; P ¼ .0003];
[regressive BC vs no BC ever; P ¼ .12]. D,WIQ distance: [persistent BC vs regressive BC; P ¼ .06]; [persistent BC vs
no BC ever; P < .0003]; [regressive BC vs no BC ever; P > .999]. E,WIQ speed: No statistically signiﬁcant differences
between the three groups. F,WIQ stair climbing: [persistent BC vs regressive BC; P ¼ .183]; [persistent BC vs no BC
ever; P ¼ .003]; [regressive BC vs no BC ever; P > .999].
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with persistent BC had signiﬁcantly poorer functional ca-
pacity, walking ability, and quality of life compared with
those with regressive BC or those who never had
claudication.
The rate of acute pelvic ischemic complications after
IOHA was 2.8%, whereas it was nil in the remaining 567
EVAR patients who did not undergo an IOHA procedure.
Previous reports describing major acute pelvic ischemia in
patients undergoing IOHA have reported rates ranging
from 0% to 18%.1-5,19-24 The factors that inﬂuence the
development of pelvic ischemia after IOHA are unknown,
but the adequacy of the pelvic collateral circulation seems
important.25 Bilateral HA interruption, failed collateral
anastomotic network, and atherothrombotic microemboli-
zation have been suggested as possible causes of acute pel-
vic ischemic complications.1-6 These disastrous occurrences
are also more likely in patients who experienced severe peri-
operative hypotension, those with associated splanchnic
arterial occlusive disease, or those with low cardiac outputdue to associated heart failure.26 Because of the low inci-
dence of acute pelvic ischemia after IOHA in this study,
we could not analyze any prognostic factor for acute pelvic
ischemic complications.
Thirty-day mortality, general complications, and cu-
mulative mortality during follow-up were in agreement
with our previously reported outcomes for EVAR patients
at high risk for open repair.16,27,28 Although acute pelvic
ischemic complications did not occur in any of the 567
contemporary EVAR patients without IOHA, the 30-day
mortality rate was not signiﬁcantly different between these
patients and the subgroup included in this analysis. With
respect to EVAR-speciﬁc complications during follow-up,
we did not observe any type II or type Ib endoleak in
the setting of previously embolized HA. This is consistent
with previous data.1-6 Deploying additional stent grafts
into EIAs may compromise long-term stent graft
patency.29 In this study, a total of six endograft limbs ipsi-
lateral to the IOHA were occluded when adverse events
were computed in both perioperative and follow-up
Fig 6. Walking Impairment Questionnaire (WIQ) score and subscores. A, WIQ pain A. B, WIQ pain B. C, WIQ
distance. D, WIQ speed. E, WIQ stair climbing. F, WIQ total score according to timing of survey completion and
patient symptom status. Error bars are 95% conﬁdence interval.
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limb occlusion warrants further exploration.
Twenty-ﬁve percent of patients experienced BC, which
had disappeared in 61% of cases during follow-up, corre-
sponding with previous literature data reporting 16% to
55% rates of BC and natural regression in 13% to 100%
of cases.25,30 Previous reports have emphasized the roleof more proximal IOHA to prevent BC.3,19,24,30-32 Consis-
tent with these data, distal IOHA for associated HA aneu-
rysm was an independent predictor of BC occurrence after
IOHA in our cohort. Surprisingly, the rate of BC did not
differ signiﬁcantly between patients with an occluded or
patent contralateral HA. The relatively small sample size
may account for these data.
JOURNAL OF VASCULAR SURGERY
48 Jean-Baptiste et al July 2014Our data also show that BC was signiﬁcantly associated
with young age. It is uncertain whether this increased risk is
solely attributable to their age rather than to their activity
level. Elderly patients are likely to have occult chronic pel-
vic ischemia because of sedentary lifestyles and possibly
more common comorbid conditions. This emphasizes the
interest in BC self-evaluation by patients and by clinicians
with use of robust qualitative tools such as the WIQ scores.
Moreover, these data provide further insight into the fact
that young patients with complex iliac anatomy should un-
dergo open repair. Alternatively, the iliac side-branch
endograft could be favored if the physiologic status of a
young patient cannot withstand an aortic cross-clamping
procedure.
Overall, the WIQ subscores were low, even in the
absence of BC. This reﬂects the high frequency of
mobility-limiting conditions in the target population (car-
diac failures, chronic obstructive pulmonary disease, osteo-
arthritis, and advanced age). The quality of life of patients
with persistent BC was signiﬁcantly more impaired com-
pared with that of patients with regressive BC and those
who never experienced BC after the IOHA procedure.
A major limitation of this study lies in the fact that we
did not assess the WIQ scores at baseline and at different
points during follow-up, thus precluding a comparison of
preoperative and postoperative quality of life. Longitudinal
quality of life data would have resulted in a more meaning-
ful comparison between patients who experienced persis-
tent BC and the controls. Another limitation is that
erectile dysfunction was not included in the ﬁelds chosen
to be investigated by a dedicated questionnaire. The pro-
funda and inferior mesenteric arteries would also be valu-
able anatomic points to investigate. However, this study
has several strengths that make the results valid and sub-
stantial. To the best of our knowledge, this is the ﬁrst study
in the world literature using the WIQ to assess functional
capacity and walking ability in patients with BC after
IOHA procedures. Our use of the validated WIQ instru-
ment contrasts with the inconsistent and subjective assess-
ment measures used in previous studies. Moreover, this
study is one of the largest and most comprehensive series
on the topic so far.
CONCLUSIONS
Pelvic ischemia associated with IOHA may be severe
and lead to fatality after EVAR. Chronic pelvic ischemia
as underlined by BC was more common and likely to be
relevant in the youngest patients who underwent distal
IOHA for associated HA aneurysm. Our data show that
BC may impair the patient’s quality of life when it does
not regress during follow-up.
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49.e1 Jean-Baptiste et al July 2014APPENDIX (online only). An English copy of the Walking Impairment Questionnaire (WIQ).I. Walking impairment: these questions ask about the reasons why you had difﬁculty walking. We would like to know how much difﬁculty
you had walking because of each of these problems during the last week. By difﬁculty, we mean how hard it was or how much
physical effort it took to walk because of each of these problems.
A. PAD-Speciﬁc Questions Leg Degree of difﬁculty Score
Right
Left
Both
None Slight Some Much Very
1. Pain, aching or cramps in your calves (or buttocks? 4 3 2 1 0
% Score ¼ (individual score/4) x 100
B. Differential Diagnosis Degree of difﬁculty Score
None Slight Some Much Very
1. Pain, stiffness, or aching in your joints (ankles, knees,
or hips)?
4 3 2 1 0
2. Weakness in one or both of your legs? 4 3 2 1 0
3. Pain or discomfort in your chest? 4 3 2 1 0
4. Shortness of breath? 4 3 2 1 0
5. Heart palpitations? 4 3 2 1 0
6. Other problems? (please list) 4 3 2 1 0
II. Walking distance: Report the degree of physical difﬁculty that best describes how hard it was for you to walk on level ground without
stopping to rest for each of the following distances during the last week:
Distance Degree of difﬁculty Weight Score
None Slight Some Much Unable Feet
1. Walking indoors such as around your home? 4 3 2 1 0 x20 ¼
2. Walking 50 feet? 4 3 2 1 0 x50 ¼
3. Walking 150 feet (1/2 block)? 4 3 2 1 0 x150 ¼
4. Walking 300 feet (1 block)? 4 3 2 1 0 x300 ¼
5. Walking 600 feet (2 blocks)? 4 3 2 1 0 x600 ¼
6. Walking 900 feet (3 blocks)? 4 3 2 1 0 x900 ¼
7. Walking 1500 feet (5 blocks)? 4 3 2 1 0 x1500 ¼
% Score ¼ (Sum individual Scores/14 080) x 100
III. Walking speed: Report the degree of physical difﬁculty that best describes how hard if was for you to walk one city block on level
ground at each of these speeds without stopping to rest during the last week:
Speed Degree of difﬁculty Weight Score
None Slight Some Much Unable Mph
1. Walking 1 block slowly? 4 3 2 1 0 x1.5 ¼
2. Walking 1 block at an average speed? 4 3 2 1 0 x2.0 ¼
3. Walking 1 block quickly? 4 3 2 1 0 x3.0 ¼
4. Running or jogging 1 block? 4 3 2 1 0 x5.0 ¼
% Score ¼ (Sum individual Scores /46) x 100
IV. Stair climbing: for each of these questions, report the degree of physical difﬁculty that best describes how hard it was for you to climb
stairs without stopping to rest during the past week:
Stairs Degree of difﬁculty Weight Score
None Slight Some Much Unable No of
stairs
1. Climbing 1 ﬂight of stairs 4 3 2 1 0 x12 ¼
2. Climbing 2 ﬂights of stairs 4 3 2 1 0 x24 ¼
3. Climbing 3 ﬂights of stairs 4 3 2 1 0 x36 ¼
% Score ¼ (Sum individual Scores/288) x 100
PAD, Peripheral arterial disease.
